These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3776749)

  • 1. 'Digoxin-like' substance in serum of elderly patients.
    Wickramasinghe LS; Bansal SK; Dillon RD
    Age Ageing; 1986 Sep; 15(5):271-7. PubMed ID: 3776749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of renal and hepatic impairment and of spironolactone on digoxin immunoassays.
    Morris RG; Frewin DB; Taylor WB; Glistak ML; Lehmann DR
    Eur J Clin Pharmacol; 1988; 34(3):233-9. PubMed ID: 3396618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An endogenous digoxin-like substance in patients with renal impairment.
    Graves SW; Brown B; Valdes R
    Ann Intern Med; 1983 Nov; 99(5):604-8. PubMed ID: 6638719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. False-positive serum digoxin concentrations determined by three digoxin assays in patients with liver disease.
    Frisolone J; Sylvia LM; Gelwan J; Pal S; Pellechia C
    Clin Pharm; 1988 Jun; 7(6):444-9. PubMed ID: 3402179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation of interference in digoxin immunoassay in renal, hepatic, and diabetic disease.
    Tzou MC; Reuning RH; Sams RA
    Clin Pharmacol Ther; 1997 Apr; 61(4):429-41. PubMed ID: 9129560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interference of digoxin-like immunoreactive substances with three digoxin immunoassays in patients with various degrees of renal function.
    Pleasants RA; Gadsden RH; McCormack JP; Piveral K; Sawyer WT
    Clin Pharm; 1986 Oct; 5(10):810-6. PubMed ID: 3780148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digoxin-like immunoreactive substance in renal failure: a reappraisal.
    Greenway DC; Nanji AA
    Nephron; 1986; 44(2):108-10. PubMed ID: 3774074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous digoxin-like immunoreactivity in elderly patients with normal serum creatinine concentrations.
    Lackner TE; Lau BW; Parvin C; Valdes R
    Clin Pharm; 1988 Jun; 7(6):449-53. PubMed ID: 3402180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digoxin-like immunoreactive substances in the plasma of intensive care unit patients: relationship to organ dysfunction.
    Howarth DM; Sampson DC; Hawker FH; Young A
    Anaesth Intensive Care; 1990 Feb; 18(1):45-52. PubMed ID: 2159733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous digoxin-like immunoreactive factors: impact on digoxin measurements and potential physiological implications.
    Valdes R
    Clin Chem; 1985 Sep; 31(9):1525-32. PubMed ID: 3896570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of renal function on plasma digoxin levels in elderly ambulant patients in domiciliary practice.
    Baylis EM; Hall MS; Lewis G; Marks V
    Br Med J; 1972 Feb; 1(5796):338-41. PubMed ID: 5008659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interference of digoxin-like immunoreactive substance in the analysis of digoxin in pulmonary pathology: preliminary results].
    Romano L; Zofra S; Imperato G; Adorno V; Maglione A
    Arch Monaldi; 1985; 40(3-4):157-64. PubMed ID: 3842060
    [No Abstract]   [Full Text] [Related]  

  • 13. A physician's office-based digoxin assay (Seralyzer) evaluated for interference by endogenous digoxin-like immunoreactive factors.
    Matheke ML; Valdes R
    Ann Clin Lab Sci; 1989; 19(3):168-74. PubMed ID: 2658726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of serum bilirubin conjugates in pediatric hepatobiliary diseases.
    Rosenthal P; Henton D; Felber S; Sinatra FR
    J Pediatr; 1987 Feb; 110(2):201-5. PubMed ID: 3806291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digoxin-like immunoreactive substances in chronic liver disease.
    Yang SS; Korula J; Sundheimer JE; Keyser AJ
    Hepatology; 1989 Mar; 9(3):363-6. PubMed ID: 2920992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum digoxin concentration in a neonate with renal and hepatic impairment.
    Ti TY; Lee HS; Tan CL
    J Paediatr Child Health; 1990 Jun; 26(3):164-5. PubMed ID: 2206620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of digoxin analysis by high-performance liquid chromatography/post-column derivatization and fluorescence polarization immunoassay.
    Embree L; McErlane KM
    Xenobiotica; 1990 Jun; 20(6):635-43. PubMed ID: 2219957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calculation of serum digoxin levels in patients with normal and impaired renal function.
    Paulson MF; Welling PG
    J Clin Pharmacol; 1976; 16(11-12):660-5. PubMed ID: 993361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anomalous serum digoxin concentrations in patients with hepatic or renal dysfunction.
    Frewin DB; Marmanidis H; Lehmann DR; Morris RG
    Aust N Z J Med; 1986 Apr; 16(2):241-3. PubMed ID: 3463280
    [No Abstract]   [Full Text] [Related]  

  • 20. Human serum bilirubin fractionation in various hepatobiliary diseases by the newly developed high performance liquid chromatography.
    Adachi Y; Inufusa H; Yamashita M; Kambe A; Yamazaki K; Sawada Y; Yamamoto T
    Gastroenterol Jpn; 1988 Jun; 23(3):268-72. PubMed ID: 3402701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.